Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab

NCT01717859 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01717859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01717859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
April 30, 2017
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis